Ontology highlight
ABSTRACT:
SUBMITTER: Ali MHM
PROVIDER: S-EPMC6789440 | biostudies-literature | 2019 Sep
REPOSITORIES: biostudies-literature
Ali Mohamed H M MHM Toor Salman M SM Rakib Fazle F Mall Raghvendra R Ullah Ehsan E Mroue Kamal K Kolatkar Prasanna R PR Al-Saad Khalid K Elkord Eyad E
Vaccines 20190909 3
Interactions between programmed death-1 (PD-1) with its ligand PD-L1 on tumor cells can antagonize T cell responses. Inhibiting these interactions using immune checkpoint inhibitors has shown promise in cancer immunotherapy. MDA-MB-231 is a triple negative breast cancer cell line that expresses PD-L1. In this study, we investigated the biochemical changes in MDA-MB-231 cells following treatment with atezolizumab, a specific PD-L1 blocker. Our readouts were Fourier Transform Infrared (FTIR) spect ...[more]